168 related articles for article (PubMed ID: 21845075)
1. A novel preparation method for camptothecin (CPT) loaded folic acid conjugated dextran tumor-targeted nanoparticles.
Zu Y; Wang D; Zhao X; Jiang R; Zhang Q; Zhao D; Li Y; Zu B; Sun Z
Int J Mol Sci; 2011; 12(7):4237-49. PubMed ID: 21845075
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of camptothecin (CPT)-loaded folate-conjugated dextran nanoparticles for tumor-targeted drug delivery using supercritical antisolvent method.
Zhao X; Wang D; Zu Y; Jiang R; Zhao D; Li Y; Zu B; Sun Z; Zhang Q
J Control Release; 2011 Nov; 152 Suppl 1():e90-2. PubMed ID: 22195950
[No Abstract] [Full Text] [Related]
3. Preparation and physicochemical properties of 10-hydroxycamptothecin (HCPT) nanoparticles by supercritical antisolvent (SAS) process.
Zhao X; Zu Y; Jiang R; Wang Y; Li Y; Li Q; Zhao D; Zu B; Zhang B; Sun Z; Zhang X
Int J Mol Sci; 2011; 12(4):2678-91. PubMed ID: 21731466
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B
Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Stability and Oral Bioavailability of Folic Acid-Dextran-Coenzyme Q
Luo M; Yang X; Ruan X; Xing W; Chen M; Mu F
J Agric Food Chem; 2018 Sep; 66(37):9690-9696. PubMed ID: 30141926
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
[TBL] [Abstract][Full Text] [Related]
7. Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method.
Zu Y; Zhao Q; Zhao X; Zu S; Meng L
Int J Nanomedicine; 2011; 6():3429-41. PubMed ID: 22267927
[TBL] [Abstract][Full Text] [Related]
8. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
[TBL] [Abstract][Full Text] [Related]
9. Loading studies of the anticancer drug camptothecin into dual stimuli-sensitive nanoparticles. Stability scrutiny.
Iglesias N; Galbis E; Díaz-Blanco MJ; de-Paz MV; Galbis JA
Int J Pharm; 2018 Oct; 550(1-2):429-438. PubMed ID: 30196142
[TBL] [Abstract][Full Text] [Related]
10. Luminescent/magnetic hybrid nanoparticles with folate-conjugated peptide composites for tumor-targeted drug delivery.
Shen JM; Guan XM; Liu XY; Lan JF; Cheng T; Zhang HX
Bioconjug Chem; 2012 May; 23(5):1010-21. PubMed ID: 22486419
[TBL] [Abstract][Full Text] [Related]
11. Techniques to develop and characterize nanosized formulation for salbutamol sulfate.
Bhavna ; Ahmad FJ; Khar RK; Sultana S; Bhatnagar A
J Mater Sci Mater Med; 2009 Dec; 20 Suppl 1():S71-6. PubMed ID: 18543087
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.
Chao P; Deshmukh M; Kutscher HL; Gao D; Rajan SS; Hu P; Laskin DL; Stein S; Sinko PJ
Anticancer Drugs; 2010 Jan; 21(1):65-76. PubMed ID: 19966540
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
[TBL] [Abstract][Full Text] [Related]
14. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
[TBL] [Abstract][Full Text] [Related]
15. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles.
Wang Z; Li Q; Zhao X; Sun B; Zhu Q; Gao W; Hua C
Int J Pharm; 2014 Apr; 465(1-2):360-7. PubMed ID: 24530520
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
[TBL] [Abstract][Full Text] [Related]
17. Supercritical antisolvent co-precipitation of rifampicin and ethyl cellulose.
Djerafi R; Swanepoel A; Crampon C; Kalombo L; Labuschagne P; Badens E; Masmoudi Y
Eur J Pharm Sci; 2017 May; 102():161-171. PubMed ID: 28302396
[TBL] [Abstract][Full Text] [Related]
18. Dextran vesicular carriers for dual encapsulation of hydrophilic and hydrophobic molecules and delivery into cells.
Pramod PS; Takamura K; Chaphekar S; Balasubramanian N; Jayakannan M
Biomacromolecules; 2012 Nov; 13(11):3627-40. PubMed ID: 23082727
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
